Status: Recruiting
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects with Obstructive Sleep Apnea (OSA) and Obesity
Participants needed: 140
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Nov 17, 2025Locations: 1
Eligibility criteria
The participant has provided informed consent and is willing and able to comply... [+5]
Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥ 3 × upper l... [+31]